A new approach to fighting cancer?
作者信息
Sato T N
机构信息
University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75235-8573, USA.
出版信息
Proc Natl Acad Sci U S A. 1998 May 26;95(11):5843-4. doi: 10.1073/pnas.95.11.5843.
Abstract
摘要
相似文献
1
A new approach to fighting cancer?一种对抗癌症的新方法？
Proc Natl Acad Sci U S A. 1998 May 26;95(11):5843-4. doi: 10.1073/pnas.95.11.5843.
2
Are angiostatin and endostatin cures for cancer?血管抑素和内皮抑素能治愈癌症吗？
Lancet. 1998 May 30;351(9116):1598-9. doi: 10.1016/S0140-6736(98)22022-8.
3
Science, medicine, and the future. Antivascular therapy: a new approach to cancer treatment.科学、医学与未来。抗血管生成疗法：一种癌症治疗的新方法。
BMJ. 1999 Mar 27;318(7187):853-6. doi: 10.1136/bmj.318.7187.853.
4
[Angiostatin. A biological inhibitor of tumor angiogenesis].[血管抑素。一种肿瘤血管生成的生物抑制剂]
Dtsch Med Wochenschr. 1997 Mar 27;122(13):413-4. doi: 10.1055/s-0029-1233709.
5
Anticancer drug targets: approaching angiogenesis.抗癌药物靶点：走近血管生成
J Clin Invest. 1999 Dec;104(11):1497-501. doi: 10.1172/JCI8849.
6
Fighting cancer by attacking its blood supply.通过攻击癌症的血液供应来对抗癌症。
Sci Am. 1996 Sep;275(3):150-4. doi: 10.1038/scientificamerican0996-150.
7
Angiogenesis: the unifying concept in cancer?
J Natl Cancer Inst. 1997 Nov 19;89(22):1658-9.
8
[Angiostatin and its antitumor activity].[血管抑素及其抗肿瘤活性]
Med Clin (Barc). 2000 Mar 25;114(11):431-6. doi: 10.1016/s0025-7753(00)71319-4.
9
10
Antiangiogenesis drugs target specific cancers, mechanisms.抗血管生成药物针对特定癌症及其机制。
J Natl Cancer Inst. 2000 Apr 5;92(7):520-2. doi: 10.1093/jnci/92.7.520.
本文引用的文献
1
Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest.血管抑素基因转移：通过阻断与有丝分裂停滞相关的内皮细胞增殖来抑制体内肿瘤生长。
Proc Natl Acad Sci U S A. 1998 May 26;95(11):6367-72. doi: 10.1073/pnas.95.11.6367.
2
Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity.PEX（一种具有整合素结合活性的非催化金属蛋白酶片段）对血管生成的破坏作用。
Cell. 1998 Feb 6;92(3):391-400. doi: 10.1016/s0092-8674(00)80931-9.
3
Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model.在小鼠模型中通过靶向药物递送作用于肿瘤血管系统进行癌症治疗。
Science. 1998 Jan 16;279(5349):377-80. doi: 10.1126/science.279.5349.377.
4
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.实验性癌症的抗血管生成疗法不会诱导获得性耐药。
Nature. 1997 Nov 27;390(6658):404-7. doi: 10.1038/37126.
5
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.内皮抑素：一种血管生成和肿瘤生长的内源性抑制剂。
Cell. 1997 Jan 24;88(2):277-85. doi: 10.1016/s0092-8674(00)81848-6.
6
Angiostatin induces and sustains dormancy of human primary tumors in mice.血管抑素可诱导并维持小鼠体内人原发性肿瘤的休眠状态。
Nat Med. 1996 Jun;2(6):689-92. doi: 10.1038/nm0696-689.
7
Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans.黑色素瘤中DNA-脂质体复合物介导的直接基因转移：在人体中的表达、生物学活性及无毒性
Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11307-11. doi: 10.1073/pnas.90.23.11307.
8
Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo.重组成纤维细胞生长因子-1在体内可促进动脉内膜增生和血管生成。
Nature. 1993 Apr 29;362(6423):844-6. doi: 10.1038/362844a0.
9
Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.血管抑素：一种新型血管生成抑制剂，可介导Lewis肺癌对转移的抑制作用。
Cell. 1994 Oct 21;79(2):315-28. doi: 10.1016/0092-8674(94)90200-3.
10
Requirement of vascular integrin alpha v beta 3 for angiogenesis.血管生成对血管整合素αvβ3的需求。
Science. 1994 Apr 22;264(5158):569-71. doi: 10.1126/science.7512751.
Zotero 插件